There are currently 28 active clinical trials seeking participants for Peripheral Artery Disease research studies. The states with the highest number of trials for Peripheral Artery Disease participants are Florida, California, Texas and Pennsylvania.
Passive Calf Stretching Therapy in Peripheral Artery Disease
NCT06041880
Recruiting
The goal of this clinical trial is to assess the effects of passive calf muscle stretching in patients diagnosed with peripheral artery disease (PAD). The main question it aims to answer are: 1. To determine if daily calf muscle stretching at home improves calf muscle and vascular health. 2. To determine if daily calf muscle stretching at home improves walking performance. Participants will use inflatable ankle splints for 30 minutes a day, 5 days a week for 4-weeks on both days and 4-weeks of... Read More
Gender:
ALL
Ages:
Between 40 years and 85 years
Trial Updated:
06/30/2024
Locations: Penn State University, University Park, Pennsylvania
Conditions: Peripheral Artery Disease, Claudication, Intermittent
Register for Updates
Intermittent Pneumatic Compression With and Without Exercise to Improve Functioning in Peripheral Artery Disease
NCT03871075
Recruiting
The INTERCEDE randomized trial will establish whether six-months of intermittent pneumatic compression combined with walking exercise improves walking endurance at six-month follow-up, compared to walking exercise + sham compression therapy, in people with lower extremity peripheral artery disease (PAD). The INTERCEDE trial will also determine whether intermittent pneumatic compression therapy improves walking endurance at 6-month follow-up, compared to a sham compression therapy. The trial will... Read More
Gender:
ALL
Ages:
55 years and above
Trial Updated:
05/02/2024
Locations: Northwestern University, Chicago, Illinois +3 locations
Conditions: Peripheral Artery Disease
Register for Updates
Far Red Light to Improve Functioning in PAD
NCT06165016
Recruiting
The LIGHT PAD Trial is a Phase II multi-centered randomized clinical trial to collect preliminary data to test whether daily far red light treatment of the lower extremities in people with PAD improves six-minute walk distance, lower extremity perfusion, and ischemia-related damage in gastrocnemius muscle at four-month follow-up, compared to a sham control. Participants will complete 10 minutes of twice daily home treatment with either far red light or a sham light for four months.
Gender:
ALL
Ages:
50 years and above
Trial Updated:
04/30/2024
Locations: Northwestern University, Chicago, Illinois
Conditions: Peripheral Artery Disease, Peripheral Vascular Disease, Aging, Walking, Difficulty
Register for Updates
Randomized Controlled Trial of Alert-Based Computerized Decision Support for Patients With Peripheral Artery Disease Not Prescribed Lipid-Lowering Therapy
NCT06300450
Recruiting
This single-center, 400-patient, randomized controlled trial assesses the impact of a patient- and provider-facing EPIC Best Practice Advisory (BPA; alert-based computerized decision support tool) to increase guideline-directed utilization of statin and statin-alternative oral LDL-C lowering therapies in patients with PAD who are not being prescribed LDL-C-lowering therapy.
Gender:
ALL
Ages:
18 years and above
Trial Updated:
03/07/2024
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Peripheral Artery Disease, Peripheral Vascular Diseases, Dyslipidemias
Register for Updates